Group 1 - IBA (Ion Beam Applications S.A.) will publish its consolidated results for the full year 2025 on Friday, 27 March 2026 at 7am CET [2] - A conference call and webcast will be hosted by IBA's management team on the same day at 3pm CET to present the half-year results, followed by a Q&A session [3] - The presentation will be available on IBA's investor relations website shortly before the call, and users are advised to register at least 15 minutes prior to the scheduled webcast [4] Group 2 - IBA is recognized as the world leader in particle accelerator technology, specializing in proton therapy, industrial sterilization, radiopharmaceuticals, and dosimetry [6] - The company is based in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people globally [6] - IBA is listed on the pan-European stock exchange EURONEXT and is a certified B Corporation, meeting high standards of social and environmental performance [7]

Company Overview - IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology and a leading supplier of equipment and services in proton therapy, which is the most advanced form of radiation therapy available today [6] - The company is also a key player in industrial sterilization, radiopharmaceuticals, and dosimetry [6] - IBA is based in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people worldwide [6] - The company is listed on the pan-European stock exchange EURONEXT [7] Upcoming Financial Results - IBA will publish its consolidated results for the half year 2025 on Thursday, 28 August 2025 at 7am CEST [2] - A conference call and webcast will be hosted by IBA's management team on the same day at 3pm CEST, which will include a Q&A session [3] - The presentation will be available on IBA's investor relations website shortly before the call [4]